Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitizodone Phosphate in Major Depressive Disorder
NCT04984512Phase 3Recruiting
- Sponsor
- Sunshine Lake Pharma
- Start
- Dec 2021
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mitizodone in major depressive disorder (MDD), sponsored by Sunshine Lake Pharma. Started Dec 2021; status: recruiting.
02
Drugs
mitizodone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04984512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04984512.